Stocks and Investing Stocks and Investing
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022
Thu, May 12, 2022

Drew Ranieri Maintained (BVS) at Buy with Decreased Target to $11 on, May 12th, 2022


Published on 2024-10-27 21:03:25 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Bioventus Inc." (BVS) at Buy with Decreased Target from $18 to $11 on, May 12th, 2022.

Drew has made no other calls on BVS in the last 4 months.



There are 2 other peers that have a rating on BVS. Out of the 2 peers that are also analyzing BVS, 1 agrees with Drew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $17 on, Monday, March 21st, 2022


This is the rating of the analyst that currently disagrees with Drew


  • Alexander Nowak of "Craig-Hallum" Initiated at Strong Buy and Held Target at $30 on, Tuesday, March 15th, 2022